BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38368603)

  • 21. Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients.
    Miller BS; Yuen KCJ
    Drug Des Devel Ther; 2022; 16():2055-2066. PubMed ID: 35791404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial.
    Maniatis AK; Nadgir U; Saenger P; Reifschneider KL; Abuzzahab J; Deeb L; Fox LA; Woods KA; Song W; Mao M; Chessler SD; Komirenko AS; Shu AD; Casella SJ; Thornton PS
    Horm Res Paediatr; 2022; 95(3):233-243. PubMed ID: 35263755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What do we do now that the long-acting growth hormone is here?
    Miller BS
    Front Endocrinol (Lausanne); 2022; 13():980979. PubMed ID: 36072938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study.
    Horikawa R; Tanaka T; Hasegawa Y; Yorifuji T; Ng D; Rosenfeld RG; Hoshino Y; Okayama A; Shima D; Gomez R; Pastrak A; Castellanos O
    Horm Res Paediatr; 2022; 95(3):275-285. PubMed ID: 35417909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and Pharmacodynamics of Once-Weekly Somapacitan in Children and Adults: Supporting Dosing Rationales with a Model-Based Analysis of Three Phase I Trials.
    Juul RV; Rasmussen MH; Agersø H; Overgaard RV
    Clin Pharmacokinet; 2019 Jan; 58(1):63-75. PubMed ID: 29671202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absorption, metabolism and excretion of once-weekly somapacitan, a long-acting growth hormone derivative, after single subcutaneous dosing in human subjects.
    Helleberg H; Bjelke M; Damholt BB; Pedersen PJ; Rasmussen MH
    Eur J Pharm Sci; 2021 Dec; 167():106030. PubMed ID: 34601071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somapacitan: a long-acting growth hormone derivative for treatment of growth hormone deficiency.
    Paton DM
    Drugs Today (Barc); 2022 Oct; 58(10):509-517. PubMed ID: 36305544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial.
    Thornton PS; Maniatis AK; Aghajanova E; Chertok E; Vlachopapadopoulou E; Lin Z; Song W; Christoffersen ED; Breinholt VM; Kovalenko T; Giorgadze E; Korpal-Szczyrska M; Hofman PL; Karpf DB; Shu AD; Beckert M
    J Clin Endocrinol Metab; 2021 Oct; 106(11):3184-3195. PubMed ID: 34272849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure identification of circulating metabolites from somapacitan, a long-acting growth hormone derivative, and pharmacokinetics after single and multiple subcutaneous dosing in rats.
    Helleberg H; Lindecrona RH; Thygesen P; Bjelke M
    Eur J Pharm Sci; 2022 Jan; 168():106032. PubMed ID: 34610450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the growth response of children with growth hormone deficiency according to the peak growth hormone levels in provocation tests.
    Donbaloğlu Z; Singin B; Acar S; Bedel A; Barsal Çetiner E; Aydın Behram B; Parlak M; Tuhan H
    Arch Pediatr; 2023 Nov; 30(8):573-579. PubMed ID: 37802668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Randomized Phase 2 Study of Long-Acting TransCon GH vs Daily GH in Childhood GH Deficiency.
    Chatelain P; Malievskiy O; Radziuk K; Senatorova G; Abdou MO; Vlachopapadopoulou E; Skorodok Y; Peterkova V; Leff JA; Beckert M;
    J Clin Endocrinol Metab; 2017 May; 102(5):1673-1682. PubMed ID: 28201598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
    Deal CL; Steelman J; Vlachopapadopoulou E; Stawerska R; Silverman LA; Phillip M; Kim HS; Ko C; Malievskiy O; Cara JF; Roland CL; Taylor CT; Valluri SR; Wajnrajch MP; Pastrak A; Miller BS
    J Clin Endocrinol Metab; 2022 Jun; 107(7):e2717-e2728. PubMed ID: 35405011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH; Wai YY; Van YH; Lo FS
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.